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Abstract 
T cell antigen receptor (TCR) is a protein-complex expressed on all T cells of the immune system 
and is responsible for the activation of T cells when infectious agent is presented by an antigen 
presenting cell (APC) in the form of peptides bound to the major histocompatibility complex 
(pMHC). Despite numerous studies it is not clear what biochemical changes upon binding of 
antigen ligand to the extracellular domains of TCR leads to activation of intracellular signaling (a 
process known as TCR triggering). This review summarizes possible biochemical mechanisms for 
TCR triggering and discusses their comparative limitations and advantages in explaining various 
experimental observations. 
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Introduction 
T cell antigen receptor (TCR or TCR-CD3) is 
a protein complex expressed exclusively in T 
cells and is composed of the variable TCR α 
and β chains and the constant CD3γ, CD3δ, 
CD3ε and CD3ζ chains (Figure 1). CD3γ and 
CD3δ chain are glycoproteins each of which 
form a heterodimer with non-glycosylated 
CD3ε chain. Along with the CD3ζ-ζ 
homodimer, these chains associate with the 
TCRαβ heterodimer to generate the full TCR-
CD3 complex [1]. The TCR-CD3 is 
responsible for activation of a T cell upon 
antigen encounter which then help in the 
activation of B cells by releasing helper 
cytokines (helper T cells) or kill the target cell 
directly by the secretion of cytotoxic effector 
molecules such as granzymes, perforin and 
granulysin. 
Antigenic ligand binding to the TCR leads to 
the phosphorylation of immunoreceptor 
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tyrosine-based activation motifs (ITAMs) of 
the CD3 complex by the Src family protein 
tyrosine kinase Lck, resulting in the 
membrane targeting and activation of another 
kinase, ZAP-70. Once activated, ZAP-70 
phosphorylates several substrates, including 
the transmembrane adaptor protein, linker for 
activation of T cells (LAT). Phospho-LAT 
serves as an important point of divergence for 
signals initiated from the TCR by recruiting 
several effector molecules to the plasma 
membrane thus initiating multiple pathways 















Fig.1: The TCR-CD3 complex. V and C represent variable and 
constant domains respectively for the TCR α  and β . The 
hypervariable region that binds to the pMHC complex is shown 
in red color. 
 
Although the downstream signaling 
mechanisms of T cell activation have been 
explored to quite detailed extent, the basic 
mechanism of how ligand binding to 
extracellular domains of TCRαβ leads to 
downstream signaling remained unclear.  
Several models of TCR triggering have been 
proposed based on the experimental findings, 
but none of the models so far could explain 
every aspect of TCR triggering. Broadly, these 
models can be grouped in three major 
processes which involve aggregation, 
conformational change or segregation (Figure 
2). This review summarizes the proposed 
models of TCR triggering and discusses their 
comparative abilities for explaining various 
experimental observations (Table 1). 
1. Antigen induced clustering  
Several forms of clustering have been 
proposed as the triggering mechanism for the 
TCR. These include homodimer, heterodimer 























































Fig.2: Various models of TCR triggering. a) Homodimer model, b) Heterodimer model, c) Pseudo-dimer model, d) Membrane binding model, 
e) Kinetic deformation model, f) Permissive geometry model, g) Kinetic segregation, h) Lipid raft mediated segregation model. Full 
description of each model is given in the main text.  
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a. Homodimer model 
Clustering of TCR–CD3 complexes following 
TCR engagement could lead to enhanced 
phosphorylation, for example by increasing 
the proximity of associated Lck molecules, 
resulting in the activation of the second 
receptor in the cluster by trans-
autophosphorylation (or this enhanced 
proximity of kinases might lead to their trans-
phosphorylation which enhance their activity 
to phosphorylate the receptor). This model is  
 
supported by the observations that artificial 
ligands such as pMHC tetramer and the anti-
TCRαβ and anti-CD3 antibodies that crosslink 
the TCR lead to its activation whereas Fab 
fragment of these antibodies or the monomeric 
pMHC in solution fail to activate the TCR [3]. 
Also the observations that MHC class I [4, 5] 
and MHC class II [6] exist in pre-formed 
clusters, support the homodimer model. 
However, since several studies have now 
shown the existence of pre-clustered TCRs on 
the T cell surface [7, 8], it is difficult to 
imagine that clustering alone could trigger the 
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TCR. In fact in a study by Schamel and 
colleagues [9], both clustering and 
conformational change were shown to be 
required for TCR triggering (permissive 
geometry model, as discussed later). 
b.  Heterodimer model 
In the heterodimer model [10], coreceptor 
CD8 or CD4 binding to the same pMHC 
complex as the TCR brings the coreceptor-
associated Lck kinase into proximity with 
TCR–CD3 ITAMs and their phosphorylation. 
Further it has been proposed that to fully 
activate the TCR, a pMHC ligand need to 
interact with a TCR–CD8 pair with a 
threshold time to induce stable zippering 
between the membrane-proximal domain of 
CD8 and the connecting peptide motif in the 
TCRα [11]. This allows stable association of 
Lck with the CD3 complex and results in 
complete phosphorylation of the CD3 ITAMs. 
A low-affinity pMHC ligand that interacts 
with a TCR–CD8 pair with less than threshold 
time induces incomplete zippering and 
therefore allows only transient Lck association 
and partial CD3 phosphorylation. However, 
the observations that T cells can develop and 
function normally in the mice lacking both 
CD4 and CD8 suggest that coreceptors are not 
absolutely required for TCR triggering and T 
cell activation [12, 13]. Also the fact that anti-
CD3 antibodies and their F(ab’)2 fragments 
that do not engage the co-receptors can still 
activate the TCR [14, 15], indicates that co-
receptors are not required for the TCR 
triggering itself, though they might be 
important for full activation of a T cell. 
c. Pseudo-dimer model 
Only a few MHCs carry high affinity agonist 
peptides for the TCRs, whereas a great 
majority of MHCs carry endogenous self-
peptides. On the basis of the crystallographic 
studies which showed that the CD4 tail 
associating with Lck was far from their own 
TCR/CD3 complex, the pseudodimer model 
postulates that two TCRs are brought together 
by binding low-affinity self or high-affinity 
agonist pMHC ligands and that the CD4 
associated with a TCR engaging the agonist 
pMHC complex can assists in phosphorylation 
of neighboring TCR (engaged to low affinity 
self peptide) by the associated kinase Lck 
[16]. Thus according to this model, a 
‘pseudodimer’ consists of one foreign and one 
self-antigen engaged receptor linked via CD4 
molecule is the primary unit of TCR signal 
initiation module. 
2. Conformational change model 
Several studies have proposed conformational 
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change as a requirement for TCR triggering 
[17, 18]. However, how the ligand binding to 
TCRαβ ectodomains leads to a 
conformational change in the cytoplasmic tails 
of CD3 subunits is not clear. The situation is 
complicated by the fact that the crystal 
structure of the fully assembled TCR-CD3 
complex is not known, although individual 
subunits have been crystallized partially [19-
22]. Some of the important models for the 
mechanism of conformational change in TCR-
CD3 are discussed below.  
a. Membrane binding model 
According to this model, cytoplasmic tails 
of CD3ε [23, 24] and CD3ζ [25] associate 
with the lipids present in the plasma 
membrane of a T cell. Thereby, the ITAMs 
are buried in the plasma membrane, 
making them inaccessible for 
phosphorylation by the kinases. Ligand 
binding leads to release of these CD3 
chains from the plasma membrane, making 
them accessible to kinase and hence the 
phosphorylation. 
b. Kinetic deformation model 
Several line of evidence have proposed that 
the mechanical effects (such as pulling or 
shearing) of pMHC binding to the TCR leads 
to a piston-like displacement of the TCR–CD3 
complex [26, 27]. This induces a change in the 
conformation of the CD3 cytoplasmic 
domains, allowing ITAM phosphorylation. 
c. Permissive geometry model 
Based on the experimental evidence for the 
existence of TCR-CD3s in a pre-clustered 
form [7] and the fact that pMHC monomers in 
solution fail to trigger TCR[28, 29] while 
pMHC dimer or higher oligomer can induce 
TCR triggering, the permissive geometry 
model was proposed[30]. According to this 
model, before ligand binding, the mono and 
multivalent TCR-CD3s exist in an 
autoinhibited state where ITAMs are 
inaccessible for phosphorylation by the kinase. 
Simultaneous dimeric (or higher order) ligand 
binding to the two TCR-CD3 complexes leads 
to a scissor-like movement in the two TCR-
CD3 complexes leading to exposure of their 
cytoplasmic tails, thus making the ITAMs 
accessible for phosphorylation.   
3. Segregation Model 
In a resting T cell, phosphorylation of the 
TCR-CD3 is kept in check by the active 
phosphotases. This is supported by the fact 
that pervanadate, a phosphatase inhibitor, 
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treatment leads to strong phosphorylation of 
the TCR-CD3 ITAMs and also initiates the 
downstream signaling [31]. Thus any process 
that favors the kinase-phosphtase balance 
towards kinase, can lead to TCR-CD3 
phosphorylation and the signaling. 
Redistribution of the TCR-CD3, kinases and 
phosphatases in which phosphatase is 
segregated from the TCR can interfere with 
the dephosphorylation. There are two 
mechanisms proposed for such ligand 
dependent re-distribution, which are discussed 
below.  
a. Kinetic segregation 
Kinetic segregation model was proposed 
based on the topological view of the cell 
surface molecules at the T cell–APC interface 
[32, 33]. The tight intercellular contact causes 
the segregation of the molecules by sizes of 
their ectodomain resulting in physical 
separation of TCR from the large inhibitory 
tyrosine phosphatase CD45, leading to stable 
phosphorylation of TCR–CD3 ITAMs by Lck. 
Though sounding good in the context of a T-
cell – APC contact, the model fails to explain 
the activation of T cells by soluble anti-
TCRαβ and anti-CD3 antibodies and the 
pMHC tetramer [14, 34]. 
b. Lipid raft mediated segregation model 
Lipid rafts are the detergent (such as Triton X-
100, Brij-series, NP-40 or CHAPS)-resistant 
membrane microdomains which are enriched 
in glycosphingolipids, cholesterol and lipid-
modified proteins such as the GPI-anchored 
proteins. Also these microdomains are 
enriched in double-acylated (myristoylated, 
palmitoylated) Src-family kinases and the 
important signaling molecules such as the 
coreceptors CD4 and CD8 and the adaptor 
protein LAT. Lipid raft mediated segregation 
model postulates that pMHC engagement 
results in partitioning of the TCR–CD3 
complex into lipid rafts enriched in Lck and 
deficient in CD45 [35, 36]. Partial support for 
this model comes from the observations that 
palmitoylation-deficient (and raft excluded) 
mutants of Lck and LAT are functionally 
defective. In addition, artificial targeting of 
other cytoplasmic molecules, such as SHP-1 
[37], CD45 [38] or PLCγ [39], to membrane 
rafts has marked functional effects on TCR-
induced signaling. A connecting peptide in the 
TCRα chain and the CD3δ chain were 
identified as the critical sites essential for 
effective raft association. Mutations in these 
components interfere with TCR signaling [40]. 
The mechanism of directing association of the 
engaged TCR complex with lipid rafts is not 
clear but might be based on co-engagement of 
the raft resident CD4/CD8 coreceptors. 




Analysis of various proposed mechanisms 
reveals that probably a combination of these 
mechanisms is responsible for TCR triggering. 
Existence of pre-clustered TCR molecules 
rules out the homodimerization as a 
requirement for TCR triggering. It is possible 
that CD3 ITAMs are inaccessible for 
phosphorylation by the kinase in the resting 
state and some sort of conformational change 
is necessary for exposing the ITAMs, but 
additional studies are required to find out what 
mechanism is responsible for such 
conformational change. Segregation models 
argue the balance of kinase mediated 
phosphorylation and phosphatase mediated 
dephosphorylation shifts in favour of kinase 
upon ligand binding. Though such segregation 
might contribute for TCR triggering in the 
context of a T cell-antigen presenting cell 
interaction, it seems not the sole mechanism of 
TCR triggering as the soluble anti-TCR or 
anti-CD3 antibodies which do not induce 
segregation can still cause TCR triggering.  
Further studies on the structure of fully 
assembled TCR-CD3 complex will be 
required for a better understanding of the TCR 
triggering. 
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